News

Published on 24 May 2022 on Bloomberg via Yahoo Finance

European Stocks Rise as Valuations Outweigh ECB Policy Concerns


Article preview image

(Bloomberg) -- European equities gained as enticing valuations outweighed concerns about tighter policy and slowing growth.

Most Read from Bloomberg

Broadcom in Talks to Acquire Cloud Company VMwareStocks Climb in Risk-On Day While Bonds Decline: Markets WrapBiden Misspeaks on Taiwan, Says US Military Would InterveneWalmart’s Troubles Should Have Everyone on High AlertGoldman’s Solomon Says Subway Shooting of Employee a ‘Senseless Tragedy’

LSE.KGF price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
European Stocks Rise as Valuations Outweigh ECB Policy Concerns

(Bloomberg) -- European equities gained as enticing valuations outweighed concerns about tighter ...

Bloomberg via Yahoo Finance 24 May 2022

KKR-led group offers record $14.8 billion bid for Australia's Ramsay Health

If successful, the takeover would rank as the biggest private equity-backed buyout of an Australi...

Reuters 20 Apr 2022

The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical...

Here's a roundup of top developments in the biotech space over the last 24 hours. Kodiak's Wet AM...

Benzinga 23 Feb 2022

Credit Suisse Set to Name David Wah, Jens Welter as Co-Heads of Banking in Promotions

(Bloomberg) -- Credit Suisse Group AG has promoted investment bankers within its senior ranks as ...

Bloomberg via Yahoo Finance 12 Jan 2022

Bankers Weigh What’s Next After Historic $5 Trillion M&A Record

(Bloomberg) -- The biggest mergers and acquisition boom in history isn’t showing signs of slowing...

Bloomberg via Yahoo Finance 28 Dec 2021

CSL Seals $11.7B Buyout Deal Of Vifor Pharma, Probably the Largest Healthcare Deal In 2021

Australian biopharma CSL Ltd (OTC: CSLLY) has agreed to acquire Vifor Pharma AG (OTC: GNHAY) for ...

Benzinga via Yahoo Finance 17 Dec 2021

Australian Shares Extend Declines, CSL Dips 8.2%

Australian Shares Extend Declines, CSL Dips 8.2%

Investing.com 16 Dec 2021

ASX Trades Lower as Fed Flags Multiple Rate Hikes for 2022

ASX Trades Lower as Fed Flags Multiple Rate Hikes for 2022

Investing.com 16 Dec 2021

Do Institutions Own Cara Therapeutics, Inc. (NASDAQ:CARA) Shares?

If you want to know who really controls Cara Therapeutics, Inc. (NASDAQ:CARA), then you'll have t...

Simply Wall St. via Yahoo Finance 14 Dec 2021

Australia’s CSL to Buy Drugmaker Vifor for $11.7 Billion

(Bloomberg) -- Australian biotech company CSL Ltd. agreed to buy Swiss drugmaker Vifor Pharma AG ...

Bloomberg via Yahoo Finance 14 Dec 2021